New UCF Nanotech Gives Boost to Detection of Cancer and Disease
The technique uses nickel-platinum nanoparticles to increase the sensitivity of an enzyme-linked immunosorbent assay, or ELISA, that is used to test for the presence of cancers, HIV and more
Early screening can mean the difference between life and death in a cancer and disease diagnosis. That’s why University of Central Florida researchers are working to develop a new screening technique that’s more than 300 times as effective at detecting a biomarker for diseases like cancer than current methods.
The technique, which was detailed recently in the Journal of the American Chemical Society, uses nanoparticles with nickel-rich cores and platinum-rich shells to increase the sensitivity of an enzyme-linked immunosorbent assay (ELISA).
ELISA is a test that measures samples for biochemicals, such as antibodies and proteins, which can indicate the presence of cancer, HIV, pregnancy and more. When a biochemical is detected, the test generates a color output that can be used to quantify its concentration. The stronger the color is, the stronger the concentration. The tests must be sensitive to prevent false negatives that could delay treatment or interventions.
In the study, the researchers found that when the nanoparticles were used in place of the conventional enzyme used in an ELISA — peroxidase — that the test was 300 times more sensitive at detecting carcinoembryonic antigen, a biomarker sometimes used to detect colorectal cancers.
And while a biomarker for colorectal cancer was used in the study, the technique could be used to detect biomarkers for other types of cancers and diseases, says Xiaohu Xia, an assistant professor in UCF’s Department of Chemistry and study co-author.
Colorectal cancer is the third leading cause of cancer-related deaths in the U.S., not counting some kinds of skin cancer, and early detection helps improve treatment outcomes, according to the U.S. Centers for Disease Control and Prevention.
The increase in sensitivity comes from nickel-platinum nanoparticle “mimics” that greatly increase the reaction efficiency of the test, which increases its color output, and thus its detection ability, Xia says.
Peroxidases found in the horseradish root have been widely used to generate color in diagnostic tests for decades. However, they have limited reaction efficiency and thus color output, which has inhibited the development of sensitive diagnostic tests, Xia says.
Nanoparticle “mimics” of peroxidase have been extensively developed over the past 10 years, but none have achieved the reaction efficiency of the nanoparticles developed by Xia and his team.
“This work sets the record for the catalytic efficiency of peroxidase mimic,” Xia says. “It breaks through the limitation of catalytic efficiency of peroxidase mimics, which is a long-standing challenge in the field.”
“Such a breakthrough enables highly sensitive detection of cancer biomarkers with the ultimate goal of saving lives through earlier detection of cancers,” he says.
Xia says next steps for the research are to continue to refine the technology and apply it to clinical samples of human patients to study its performance.
“We hope the technology can be eventually used in clinical diagnostic laboratories in the near future,” Xia says.
Original Article: New UCF Nanotech Gives Boost to Detection of Cancer and Disease
More from: University of Central Florida | Brown University | University of Texas at Dallas | Oak Ridge National Laboratory
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Enzyme-linked immunosorbent assay
- Immunoprotein Diagnostic Testing Market Art of Listening How Focus Groups Amplify Qualitative Research Impact
Immunoprotein Diagnostic Testing Market is valued approximately at USD 10.1 billion in 2019 and is anticipated to grow with a growth rate of more than 6.6% over the forecast period 2020-2027.
- Therapeutic potential of human umbilical cord-derived mesenchymal stem cells in Crohn’s disease
Whether human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) could heal luminal ulcers in Crohn’s disease.
- COVID Shot Boosts Mucosal Immunity in Previously Infected People
COVID-19 mRNA vaccines stimulated mucosal immunity in people previously infected with SARS-CoV-2, but generated only a tiny amount of immunity in people who had never been infected, according to a ...
- Cancer test launches within US and European veterinary clinics
VolitionRx Limited announced that its Nu. Q Vet Cancer Test is now available to veterinarians across the United States and Europe through Antech, a veterinary diagnostics company. The Antech version ...
- Previous hepatitis E virus infection is associated with increased liver stiffness in patients with autoimmune hepatitis
Introduction: Autoimmune hepatitis (AIH) is a chronic, progressive liver disease which, in most cases, may require lifelong immunosuppression. Hepatitis E virus (HEV) is a leading cause of acute, ...
Go deeper with Google Headlines on:
Enzyme-linked immunosorbent assay
[google_news title=”” keyword=”enzyme-linked immunosorbent assay” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Detection of cancer biomarkers
- New test reveals Cancer within minutes
ALBAWABA In a significant stride towards early cancer detection, researchers have developed an innovative AI-powered test capable of identifying three m ...
- mRNA Is Promising A Breakthrough In Fighting Cancer
When it comes to cancer, there’s innovation both on the diagnostics and the treatment front thanks to messenger RNA, or mRNA, a genetic material we all got acquainted with during the COVID-19 era as ...
- Researchers develop tiny droplets that harness laser light to detect disease markers
A team of researchers led by Nanyang Technological University, Singapore (NTU Singapore) has created tiny droplets that, when activated by laser light, can detect viral protein biomarkers indicating ...
- New blood test shows promise in early detection of ovarian cancer
A study reveals that glycoproteins in blood could be key biomarkers for early detection and staging of epithelial ovarian cancer, potentially allowing diagnosis through a simple blood test.
- ProteoGenix and Cizzle Biotechnology Collaboration Forges New Paths in Early Detection of Lung Cancer through Innovative Antibody Development
As this blood test advances toward U.S. clinical trials and aims for rapid commercialization, this collaboration sets a new industry standard in the fight against lung cancer, by combining ProteoGenix ...
Go deeper with Google Headlines on:
Detection of cancer biomarkers
[google_news title=”” keyword=”detection of cancer biomarkers” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]